News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
883,895 Results
Type
Article (88826)
Company Profile (744)
Press Release (794304)
Multimedia
Podcasts (240)
Webinars (35)
Section
Business (233610)
Career Advice (4164)
Deals (40004)
Drug Delivery (179)
Drug Development (91727)
Employer Resources (207)
FDA (18560)
Job Trends (17491)
News (398771)
Policy (40017)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3054)
Academic (1)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (206)
Alliances (56989)
ALS (241)
Alzheimer's disease (1978)
Antibody-drug conjugate (ADC) (564)
Approvals (18931)
Artificial intelligence (860)
ASCO (344)
Autoimmune disease (362)
Automation (67)
Bankruptcy (408)
Best Places to Work (12632)
BIO (68)
BIOSECURE Act (23)
Biosimilars (250)
Biotechnology (449)
Bladder cancer (210)
Brain cancer (84)
Breast cancer (841)
Cancer (6635)
Cardiovascular disease (560)
Career advice (3600)
Career pathing (52)
CAR-T (388)
CDC (77)
Celiac Disease (3)
Cell therapy (1068)
Cervical cancer (56)
Clinical research (79120)
Collaboration (2405)
Commercialization (1)
Company closure (8)
Compensation (1541)
Complete response letters (106)
COVID-19 (3040)
CRISPR (127)
C-suite (1311)
Cystic fibrosis (168)
Data (8819)
Decentralized trials (3)
Denatured (92)
Depression (198)
Dermatology (99)
Diabetes (713)
Diagnostics (7606)
Digital health (70)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (419)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (320)
Earnings (102454)
Editorial (80)
Employer branding (25)
Employer resources (175)
Events (138719)
Executive appointments (1205)
FDA (22693)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1974)
Gene editing (274)
Generative AI (80)
Gene therapy (854)
GLP-1 (1285)
Government (5564)
Grass and pollen (8)
Guidances (421)
Healthcare (21244)
Hematology (197)
HIV (96)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (358)
Immuno-oncology (116)
Indications (217)
Infectious disease (3443)
Inflammatory bowel disease (245)
Inflation Reduction Act (17)
Influenza (152)
Intellectual property (326)
Interviews (822)
IPO (18003)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (22)
Labor market (125)
Layoffs (690)
Leadership (54)
Legal (10170)
Liver cancer (111)
Longevity (37)
Lung cancer (878)
Lymphoma (483)
Machine learning (68)
Management (67)
Manufacturing (1249)
Marketing (2)
MASH (229)
Medical affairs (1)
Medical device (15271)
Medtech (15444)
Mergers & acquisitions (23310)
Metabolic disorders (1839)
mRNA (273)
Multiple sclerosis (209)
NASH (24)
Neurodegenerative disease (517)
Neuropsychiatric disorders (130)
Neuroscience (3757)
Neurotech (1)
NextGen: Class of 2026 (7696)
Non-profit (5145)
Now hiring (82)
Obesity (871)
Opinion (377)
Ovarian cancer (246)
Pain (287)
Pancreatic cancer (365)
Parkinson's disease (421)
Partnered (39)
Patents (664)
Patient recruitment (781)
Peanut (71)
People (68047)
Pharmaceutical (130)
Pharmacy benefit managers (38)
Phase 1 (24450)
Phase 2 (34383)
Phase 3 (25853)
Pipeline (9989)
Policy (402)
Postmarket research (3560)
Preclinical (10985)
Press Release (72)
Prostate cancer (352)
Psychedelics (72)
Radiopharmaceuticals (374)
Rare diseases (1290)
Real estate (7462)
Recruiting (81)
Regulatory (30484)
Reports (77)
Research institute (2765)
Resumes & cover letters (654)
Rett syndrome (44)
RNA editing (30)
RSV (100)
Schizophrenia (197)
Series A (340)
Series B (245)
Service/supplier (27)
Sickle cell disease (129)
Special edition (32)
Spinal muscular atrophy (191)
Sponsored (55)
Startups (4373)
State (2)
Stomach cancer (21)
Supply chain (149)
Tariffs (104)
The Weekly (145)
Vaccines (1314)
Venture capital (139)
Weight loss (598)
Women's health (144)
Worklife (25)
Date
Today (107)
Last 7 days (495)
Last 30 days (2783)
Last 365 days (32790)
2026 (16832)
2025 (32799)
2024 (37968)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (406)
Arkansas (16)
Asia (52342)
Australia (9197)
California (14475)
Canada (4030)
China (1601)
Colorado (622)
Connecticut (645)
Delaware (448)
Europe (120679)
Florida (2164)
Georgia (469)
Hawaii (4)
Idaho (70)
Illinois (1254)
India (104)
Indiana (672)
Iowa (26)
Japan (610)
Kansas (143)
Kentucky (57)
Louisiana (64)
Maine (82)
Maryland (1752)
Massachusetts (10603)
Michigan (411)
Minnesota (799)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (91)
New Jersey (3815)
New Mexico (35)
New York (3807)
North Carolina (1942)
North Dakota (11)
Northern California (7208)
Ohio (453)
Oklahoma (27)
Oregon (53)
Pennsylvania (2843)
Puerto Rico (33)
Rhode Island (55)
South America (1668)
South Carolina (89)
South Dakota (2)
Southern California (5696)
Tennessee (231)
Texas (2348)
United States (51730)
Utah (433)
Vermont (2)
Virginia (372)
Washington D.C. (89)
Washington State (1188)
West Virginia (4)
Wisconsin (158)
Wyoming (2)
883,895 Results for "pharma bio serv us inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2026
June 16, 2026
·
2 min read
Press Releases
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2026
March 18, 2026
·
2 min read
Drug pricing
Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling
As Big Pharma companies consider foregoing European drug launches to avoid reducing drug prices in the U.S. in alignment with Trump’s Most Favored Nation policy, patients will suffer.
April 2, 2026
·
3 min read
·
Annalee Armstrong
Drug pricing
BIO 2026: Biopharma dealmakers seek to protect ‘premium pricing’ from Trump’s MFN policy
With drug pricing now embedded in U.S. policy, business development teams in biotech and pharma are changing the way they strike deals, including acknowledging policy uncertainties with renegotiation clauses.
June 23, 2026
·
2 min read
·
Annalee Armstrong
Policy
BIO 2026: US public health as we know it is gone. Can we rebuild a better system?
Former FDA, CDC and NIH leaders convene at the BIO International Convention to discuss the dismantling of the Department of Health and Human Services under the Trump administration—and where we go from here.
June 23, 2026
·
4 min read
·
Jef Akst
Press Releases
Pharma-Bio Serv Announces Full Year Results and Special Dividend - January 29, 2026
January 30, 2026
·
3 min read
Manufacturing
How US pharma manufacturing pay stacks up to other jobs in the industry
Anticipated to be one of fastest-growing jobs in manufacturing, pharmaceutical jobs offer a salary 32% higher than the average U.S. manufacturing role.
June 23, 2026
·
1 min read
·
Gabrielle Masson
Mergers & acquisitions
Mid-sized European drugmakers are snapping up US biotechs. Will the surge continue?
European pharma companies splashed billions of dollars into the U.S. biopharma sector in a matter of days, but there are differing views on whether the activity represents the rise of a new buyer class or a quirk of timing.
May 13, 2026
·
4 min read
·
Nick Paul Taylor
Press Releases
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing
April 16, 2026
·
5 min read
Press Releases
Knoa Pharma to Present Pipeline Assets at BIO International Convention 2026
June 22, 2026
·
4 min read
1 of 88,390
Next
